Investor Relations

Overview

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More
Webcast ImageWebcast
MyoKardia Inc at the 2017 Cantor Fitzgerald Global Healthcare Conference  (Live)
September 27, 2017 at 8:00 a.m. ET
MyoKardia Inc at the 2017 Cantor Fitzgerald Global Healthcare Conference
Wednesday, September 27, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent Press Releases

Upcoming Events